{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:26:12Z","timestamp":1791822372933,"version":"4.3.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T00:00:00Z","timestamp":1522195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.vaccine.2018.02.089","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T09:22:14Z","timestamp":1522747334000},"page":"7437-7442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"title":["Vaccination against the human cytomegalovirus"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4950-7016","authenticated-orcid":false,"given":"Stanley A.","family":"Plotkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh B.","family":"Boppana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2018.02.089_b0005","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/bdra.23601","article-title":"Cytomegalovirus infection in pregnancy","volume":"109","author":"Davis","year":"2017","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.vaccine.2018.02.089_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.hemonc.2017.05.001","article-title":"Emerging concepts in cytomegalovirus infection following hematopoietic stem cell transplantation","author":"Camargo","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2018.02.089_b0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2018.02.089_b0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2018.02.089_b0025","unstructured":"Boppana SB, Britt WJ. Synopsis of clinical aspects of human cytomegalovirus disease. In: Reddehase MJ, editor. Cytomegaloviruses: from molecular pathogenesis to intervention, vol. II. Norfolk, U.K.: Caister Academic Press; 2013. p. 1\u201325."},{"key":"10.1016\/j.vaccine.2018.02.089_b0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijid.2013.12.010","article-title":"Systematic reivew of the birth prevalence of congenital cytomegalovirus infection in developing countries","volume":"22","author":"Lanzieri","year":"2014","journal-title":"Int Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2018.02.089_b0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The \u201csilent\u201d globar burden of congenital cytomegalovirus","volume":"26","author":"Manicklal","year":"2013","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2018.02.089_b0040","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jcv.2009.09.002","article-title":"Congenital cytomegalovirus (CMV) epidemiology and awareness","volume":"46","author":"Cannon","year":"2009","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.089_b0045","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jcv.2005.09.016","article-title":"Congenital cytomegalovirus (CMV) infection and hearing deficit","volume":"35","author":"Fowler","year":"2005","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.089_b0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00006454-199202000-00007","article-title":"Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality","volume":"11","author":"Boppana","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.02.089_b0055","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2018.02.089_b0060","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/clinids\/13.2.315","article-title":"Infectious diseases society of America and centers for disease control. Summary of a workshop on surveillance for congenital cytomegalovirus disease","volume":"13","author":"Demmler","year":"1991","journal-title":"Rev Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2018.02.089_b0065","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1542\/peds.90.6.862","article-title":"Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection","volume":"90","author":"Williamson","year":"1992","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2018.02.089_b0070","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/JCM.30.3.721-723.1992","article-title":"Evaluation of a microtiter plate fluorescent antibody assay for rapid detection of human cytomegalovirus infections","volume":"30","author":"Boppana","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.02.089_b0075","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/infdis\/167.6.1433","article-title":"Neonatal screening for congenital cytomegalovirus infection by detection of virus in saliva","volume":"167","author":"Balcarek","year":"1993","journal-title":"J Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2018.02.089_b0080","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa1006561","article-title":"Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns","volume":"364","author":"Boppana","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2018.02.089_b0085","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1371\/journal.pone.0000492","article-title":"Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort","volume":"2","author":"van der Sande","year":"2007","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.vaccine.2018.02.089_b0090","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/INF.0b013e31822d9640","article-title":"Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly seropositive population","volume":"30","author":"Yamamoto","year":"2011","journal-title":"Ped Infect Dis J"},{"issue":"7","key":"10.1016\/j.vaccine.2018.02.089_b0095","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/INF.0000000000001527","article-title":"Congenital cytomegalovirus infection and permanent hearing loss in children in rural north India","volume":"36","author":"Dar","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"15","key":"10.1016\/j.vaccine.2018.02.089_b0100","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02392-16","article-title":"Congenital human cytomegalovirus infection and the enigma of maternal immunity","volume":"91","author":"Britt","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.02.089_b0105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/infdis\/164.2.259","article-title":"Sexually transmitted diseases in mothers of neonates with congenital cytomegalovirus infection","volume":"164","author":"Fowler","year":"1991","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2018.02.089_b0110","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/cid\/cix337","article-title":"Risk factors for congenital cytomegalovirus infection following primary and nonprimary maternal infection: a prospective neonatal screening study using polymerase chain reaction in saliva","volume":"65","author":"Leruez-Ville","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.089_b0115","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1093\/cid\/ciq085","article-title":"Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection","volume":"52","author":"Wang","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2018.02.089_b0120","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/rmv.1744","article-title":"The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: a population-based prediction model","volume":"23","author":"de Vries","year":"2013","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2018.02.089_b0125","article-title":"Perinatal outcomes of non-primary maternal cytomegalovirus infection: a 15-year experience","author":"Simonazzi","year":"2017","journal-title":"Fetal Diagn Ther"},{"issue":"16","key":"10.1016\/j.vaccine.2018.02.089_b0130","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1056\/NEJM198204223061601","article-title":"Congenital cytomegalovirus infection: the relative importance of primary and recurrent maternal infection","volume":"306","author":"Stagno","year":"1982","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.vaccine.2018.02.089_b0135","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1001\/jama.1986.03380140074025","article-title":"Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus and clinical outcome","volume":"256","author":"Stagno","year":"1986","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.vaccine.2018.02.089_b0140","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1056\/NEJM200105033441804","article-title":"Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity","volume":"344","author":"Boppana","year":"2001","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2018.02.089_b0145","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1086\/649903","article-title":"Cytomegalovirus reinfections in healthy seroimmune women","volume":"201","author":"Ross","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.089_b0150","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/infdis\/171.5.1115","article-title":"Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection","volume":"171","author":"Boppana","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.089_b0155","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/jmv.23691","article-title":"Slow increase in IgG avidity correlates with prevention of human cytomegalovirus transmission to the fetus","volume":"85","author":"Furione","year":"2013","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2018.02.089_b0160","doi-asserted-by":"crossref","first-page":"e59863","DOI":"10.1371\/journal.pone.0059863","article-title":"Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH\/gL\/pUL128-130-131 complex during primary infection","volume":"8","author":"Lilleri","year":"2013","journal-title":"PLoS One"},{"issue":"Suppl 7","key":"10.1016\/j.vaccine.2018.02.089_b0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12594","article-title":"Cytomegalovirus infection in solid organ transplant recipients","volume":"20","author":"Lumbreras","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.vaccine.2018.02.089_b0170","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/tri.12629","article-title":"Cytomegalovirus post kidney transplantation: prophylaxis versus pre-emptive therapy?","volume":"28","author":"Fehr","year":"2015","journal-title":"Transpl Int"},{"issue":"3","key":"10.1016\/j.vaccine.2018.02.089_b0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.trre.2016.04.001","article-title":"Management of cytomegalovirus infection in solid organ transplant recipients: SET\/GESITRA-SEIMC\/REIPI recommendations","volume":"30","author":"Torre-Cisneros","year":"2016","journal-title":"Transplant Rev (Orlando)"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.089_b0180","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jceh.2017.05.011","article-title":"Cytomegalovirus infection in liver transplant recipients: current approach to diagnosis and management","volume":"7","author":"Yadav","year":"2017","journal-title":"J Clin Exp Hepatol"},{"issue":"23","key":"10.1016\/j.vaccine.2018.02.089_b0185","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1182\/blood-2008-10-143560","article-title":"How we treat cytomegalovirus in hematopoietic cell transplant recipients","volume":"113","author":"Boeckh","year":"2009","journal-title":"Blood"},{"issue":"2 Suppl","key":"10.1016\/j.vaccine.2018.02.089_b0190","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.bbmt.2014.12.034","article-title":"Reprint of: recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies","volume":"21","author":"Boeckh","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.vaccine.2018.02.089_b0195","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.blre.2017.01.002","article-title":"The clinical impact of cytomegalovirus infection following allogeneic hematopoietic cell transplantation: why the quest for meaningful prophylaxis still matters","volume":"31","author":"Chan","year":"2017","journal-title":"Blood Rev"},{"issue":"7845","key":"10.1016\/j.vaccine.2018.02.089_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(74)92997-3","article-title":"Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero","volume":"1","author":"Elek","year":"1974","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2018.02.089_b0205","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/IAI.12.3.521-527.1975","article-title":"Candidate cytomegalovirus strain for human vaccination","volume":"12","author":"Plotkin","year":"1975","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2018.02.089_b0210","first-page":"1176","article-title":"Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients","volume":"58","author":"Plotkin","year":"1994","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.vaccine.2018.02.089_b0215","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/infdis\/159.5.860","article-title":"Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge","volume":"159","author":"Plotkin","year":"1989","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2018.02.089_b0220","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/infdis\/jiw365","article-title":"A phase 1 study of 4 live, recombinant human cytomegalovirus towne\/toledo chimera vaccines in cytomegalovirus-seronegative men","volume":"214","author":"Adler","year":"2016","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2018.02.089_b0225","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"Pass","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2018.02.089_b0230","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","article-title":"Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: a randomized clinical trial","volume":"34","author":"Bernstein","year":"2016","journal-title":"Vaccine"},{"issue":"9773","key":"10.1016\/j.vaccine.2018.02.089_b0235","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(11)60136-0","article-title":"Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial","volume":"377","author":"Griffiths","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.02.089_b0240","unstructured":"Institute of Medicine Committee to Study Priorities for Vaccine, D. The national academies collection: reports funded by national institutes of health. In: Stratton KR, Durch JS, Lawrence RS, editors. Vaccines for the 21st century: a tool for decision making. Washington (DC): National Academies Press (US); 2000."},{"issue":"50","key":"10.1016\/j.vaccine.2018.02.089_b0245","doi-asserted-by":"crossref","first-page":"18153","DOI":"10.1073\/pnas.0509201102","article-title":"Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism","volume":"102","author":"Wang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.089_b0250","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1921","article-title":"Maternal immune correlates of protection from human cytomegalovirus transmission to the fetus after primary infection in pregnancy","volume":"27","author":"Lilleri","year":"2017","journal-title":"Rev Med Virol"},{"issue":"22","key":"10.1016\/j.vaccine.2018.02.089_b0255","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.vaccine.2014.03.057","article-title":"Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease","volume":"32","author":"Fu","year":"2014","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2018.02.089_b0260","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/319680","article-title":"A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects","volume":"183","author":"Berencsi","year":"2001","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2018.02.089_b0265","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1086\/511982","article-title":"Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection","volume":"195","author":"Schleiss","year":"2007","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.089_b0270","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.vaccine.2009.09.135","article-title":"Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers","volume":"28","author":"Bernstein","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2018.02.089_b0275","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nm.2104","article-title":"Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity","volume":"16","author":"Flatz","year":"2010","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.089_b0280","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1128\/CVI.00662-13","article-title":"Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activity","volume":"21","author":"Kirchmeier","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2018.02.089_b0285","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1182\/blood-2016-07-729756","article-title":"MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults","volume":"129","author":"La Rosa","year":"2017","journal-title":"Blood"},{"issue":"Pt 12","key":"10.1016\/j.vaccine.2018.02.089_b0290","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1099\/vir.0.025742-0","article-title":"Delineating the role of CD4+ T cells in the activation of human cytomegalovirus-specific immune responses following immunization with Ad-gBCMVpoly vaccine: implications for vaccination of immunocompromised individuals","volume":"91","author":"Zhong","year":"2010","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.089_b0295","first-page":"129","article-title":"Intranasal immunization with recombinant vesicular stomatitis virus expressing murine cytomegalovirus glycoprotein B induces humoral and cellular immunity","volume":"58","author":"Wilson","year":"2008","journal-title":"Comp Med"},{"issue":"8","key":"10.1016\/j.vaccine.2018.02.089_b0300","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/infdis\/jis107","article-title":"Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant","volume":"205","author":"La Rosa","year":"2012","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2018.02.089_b0305","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1086\/588385","article-title":"Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects","volume":"197","author":"Wloch","year":"2008","journal-title":"J Infect Dis"},{"issue":"36","key":"10.1016\/j.vaccine.2018.02.089_b0310","doi-asserted-by":"crossref","first-page":"14604","DOI":"10.1073\/pnas.1209367109","article-title":"Nonviral delivery of self-amplifying RNA vaccines","volume":"109","author":"Geall","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2018.02.089_b0315","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3390\/vaccines1040398","article-title":"Clinical development of a cytomegalovirus DNA vaccine: from product concept to pivotal phase 3 trial","volume":"1","author":"Smith","year":"2013","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.089_b0320","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/S2352-3026(15)00246-X","article-title":"Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial","volume":"3","author":"Nakamura","year":"2016","journal-title":"Lancet Haematol"},{"issue":"20","key":"10.1016\/j.vaccine.2018.02.089_b0325","doi-asserted-by":"crossref","first-page":"11107","DOI":"10.1128\/JVI.01554-13","article-title":"Cytomegalovirus vaccine strain towne-derived dense bodies induce broad cellular immune responses and neutralizing antibodies that prevent infection of fibroblasts and epithelial cells","volume":"87","author":"Cayatte","year":"2013","journal-title":"J Virol"},{"issue":"14","key":"10.1016\/j.vaccine.2018.02.089_b0330","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMoa1310214","article-title":"A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus","volume":"370","author":"Revello","year":"2014","journal-title":"N Engl J Med"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2018.02.089_b0335","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1093\/cid\/cit586","article-title":"Hyperimmunoglobulin for prevention of congenital cytomegalovirus disease","volume":"57","author":"Nigro","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"30","key":"10.1016\/j.vaccine.2018.02.089_b0340","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1016\/j.vaccine.2014.05.014","article-title":"Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infection","volume":"32","author":"Lanzieri","year":"2014","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18302883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18302883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T18:26:17Z","timestamp":1660760777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18302883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":68,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0264410X18302883"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.089","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination against the human cytomegalovirus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}